Ctxr offering
Web2 days ago · Company Profile CTXR. Business Description. Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, unique … WebMay 7, 2024 · Citius Pharmaceuticals, Inc. (NASDAQ: CTXR) is a late-stage biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products, with a focus on...
Ctxr offering
Did you know?
WebCitius Pharmaceuticals Inc (CTXR) Try Excel Alerts Watch Help Go To: Full Chart Realtime quote and/or trades are not sourced from all markets. Fundamentals Market Capitalization, $K 200,373 Shares Outstanding, K 146,258 Annual Sales, $ 0 K Annual Income, $ -33,640 K 60-Month Beta 1.38 Price/Sales N/A Price/Cash Flow N/A … WebFeb 19, 2024 · It’s worth noting that the company announced a direct offering on Wednesday for 50,830,566 shares and warrants for another 25,415,283 shares. That …
WebApr 11, 2024 · About Citius Pharmaceuticals (NASDAQ:CTXR) Stock Citius Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of critical care products, with a focus on oncology, anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. WebApr 9, 2024 · The S&P 500 ticked slightly higher Monday as investors looked ahead to key inflation data this week. The broader index rose 0.1% to 4,109.11. The Dow Jones Industrial Average added 101.23 points ...
WebCTXR Stock 12 Months Forecast. $5.00. (327.35% Upside) Based on 2 Wall Street analysts offering 12 month price targets for Citius Pharmaceuticals in the last 3 months. The … WebMay 6, 2024 · CRANFORD, N.J. , May 6, 2024 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR ), a late-stage biopharmaceutical company developing and commercializing...
WebCTXR Analyst Research CTXR Analyst Ratings Consensus Strong Buy Based on 3 analysts offering recommendations for 'CTXR' in the last 3 months. Analyst Firms Making Recommendations DAWSON...
WebCitius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR) , a late-stage biopharmaceutical company developing and commercializing first-in-class critical care … crystal springs water account log inWebSelling Calls For Income. Selling Puts For Income. My Watchlist. Interesting CTXR Contracts. Our YieldBoost Rank identified this particular CTXR option as an interesting … crystal springs water albuquerqueWebApr 10, 2024 · Citius Pharmaceuticals, Inc., a late-stage pharmaceutical company, engages in the development and commercialization of critical care products focusing on oncology products, anti-infectives products in adjunct cancer care, prescription products, and stem cell therapy. About the company. CTXR fundamental analysis. Snowflake Score. Valuation. 1 … dyna glo wall heater replacement brickdyna-glo wall heater base legsWebJan 25, 2024 · Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR ), a specialty pharmaceutical company focused on developing and commercializing critical care drug products, today announced... crystal springs water appWebFeb 17, 2024 · CRANFORD, N.J., Feb. 17, 2024-- Citius Pharmaceuticals, Inc. (Nasdaq: CTXR) ("Citius" or the "Company"), a specialty pharmaceutical company focused on … dyna glo turbo heaterWebFeb 19, 2024 · It was founded in 2010 and joined the public market via an initial public offering (IPO) in September 2014. ... N.J. CTXR stock was up 23.8% as of Friday … crystal springs water abq